Matthias Schwenkglenks Selected Research

Therapeutics

3/2024	Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany.
1/2022	Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer.
8/2020	Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter.
4/2019	Non-Pharmacological Methods and Post-Operative Pain Relief: An Observational Study.
1/2019	Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis.
11/2018	A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC).
1/2018	Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial.
2/2015	Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.
2/2015	Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.
1/2015	Cancer-related therapies at the end of life in hospitalized cancer patients from four Swiss cantons: SAKK 89/09.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Schwenkglenks Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2006
10	Febrile Neutropenia 07/2015 - 11/2008
8	Heart Failure 08/2020 - 06/2006
7	Neutropenia 02/2015 - 09/2006
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2014 - 03/2008
6	Neoplasms (Cancer) 02/2015 - 05/2013
5	Hemorrhage 03/2024 - 01/2011
5	Atrial Fibrillation 01/2024 - 01/2020
5	Stroke (Strokes) 01/2024 - 10/2013
3	Hypertension (High Blood Pressure) 12/2023 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 12/2016
3	Acute Coronary Syndrome 01/2022 - 01/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 01/2012
3	ST Elevation Myocardial Infarction 01/2018 - 04/2012
3	Colorectal Neoplasms (Colorectal Cancer) 12/2016 - 10/2011
3	Infections 04/2013 - 03/2009
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2012 - 03/2012
2	Chronic Disease (Chronic Diseases) 01/2021 - 01/2021
2	Myocardial Infarction 12/2020 - 06/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2020 - 01/2002
2	Venous Thromboembolism 11/2019 - 11/2017
2	Pain (Aches) 04/2019 - 09/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 03/2017
2	Intervertebral Disc Displacement (Herniated Disc) 12/2016 - 01/2016
2	Radiculopathy (Radiculopathy, Cervical) 12/2016 - 01/2016
2	Death (Near-Death Experience) 01/2015 - 05/2014
2	Iron Deficiencies 10/2013 - 07/2012
2	Lung Neoplasms (Lung Cancer) 05/2013 - 01/2012
2	Anemia 01/2013 - 05/2011
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2024
1	Hemophilia A (Haemophilia) 03/2024
1	Hemophilia B (Haemophilia B) 03/2024
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023
1	Coronary Disease (Coronary Heart Disease) 12/2023
1	Transient Ischemic Attack 12/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2022
1	Blindness (Hysterical Blindness) 06/2022
1	Inguinal Hernia (Direct Inguinal Hernia) 10/2021
1	Varicose Veins (Varicose Vein) 10/2021
1	Chronic Progressive Multiple Sclerosis 01/2021
1	Multiple Sclerosis 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021

Drug/Important Bio-Agent (IBA)

6	Rituximab (Mabthera)FDA Link 07/2022 - 05/2011
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2014 - 03/2009
4	Hormones (Hormone)IBA 12/2022 - 02/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 08/2010
3	LipidsIBA 12/2023 - 06/2009
3	Docetaxel (Taxotere)FDA Link 01/2022 - 03/2014
3	Bevacizumab (Avastin)FDA Link 12/2016 - 05/2009
3	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2015 - 11/2008
3	IronIBA 10/2013 - 07/2012
3	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 05/2011
3	Prednisolone (Predate)FDA LinkGeneric 01/2013 - 05/2011
2	Vitamin K FDA Link 01/2024 - 01/2021
2	AnticoagulantsIBA 12/2023 - 01/2021
2	Antidepressive Agents (Antidepressants)IBA 01/2023 - 09/2020
2	ALN-PCSIBA 08/2022 - 01/2022
2	palbociclibIBA 01/2022 - 10/2021
2	Epirubicin (Ellence)FDA LinkGeneric 07/2015 - 03/2014
2	AnthracyclinesIBA 07/2015 - 04/2011
2	pegfilgrastim (Neulasta)FDA Link 02/2015 - 06/2010
2	human ERBB2 proteinIBA 02/2015 - 11/2010
2	Trastuzumab (Herceptin)FDA Link 10/2014 - 11/2010
2	Cetuximab (Erbitux)FDA Link 10/2014 - 10/2011
2	Monoclonal AntibodiesIBA 10/2014 - 10/2011
2	ferric carboxymaltoseIBA 10/2013 - 07/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2012 - 05/2012
2	Glycoproteins (Glycoprotein)IBA 04/2012 - 01/2011
2	Heparin (Liquaemin)FDA LinkGeneric 04/2012 - 01/2011
2	bivalirudin (Angiomax)FDA Link 04/2012 - 01/2011
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 03/2024
1	Factor Xa InhibitorsIBA 01/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	venetoclaxIBA 07/2022
1	Retinaldehyde (Retinal)IBA 06/2022
1	abirateroneIBA 01/2022
1	enzalutamideIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	AndrogensIBA 01/2022
1	apalutamideIBA 01/2022
1	Letrozole (Femara)FDA LinkGeneric 10/2021
1	Interferon beta-1a FDA Link 01/2021
1	siponimodIBA 01/2021
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	Denosumab FDA Link 01/2021

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 12/2019 - 09/2006
16	Therapeutics 03/2024 - 01/2003
2	Polypharmacy 01/2021 - 01/2021
2	Transplantation 01/2019 - 03/2008
2	Conservative Treatment 12/2016 - 01/2016
2	Radiotherapy 07/2015 - 05/2014
2	Percutaneous Coronary Intervention 01/2014 - 04/2012
1	Intravenous Infusions 03/2024
1	Neoadjuvant Therapy 01/2022
1	Meniscectomy 10/2021
1	Mastectomy (Mammectomy) 01/2021
1	Castration 01/2021
1	Secondary Prevention 12/2020